Literature DB >> 8178678

Interrater reliability of the Structured Clinical Interview for the Positive and Negative Syndrome Scale for schizophrenia.

E Lindström1, I M Wieselgren, L von Knorring.   

Abstract

The Swedish version of the Positive and Negative Syndrome Scale for schizophrenia (PANSS) has been tested and construct validity, internal reliability and interrater reliability have been demonstrated to be quite satisfactory. However, the interrater reliability of the negative symptoms was unsatisfactory low. In this study, the Swedish version of the Structured Clinical Interview for the PANSS has been tested. The interrater reliability is increased as compared with the inter-rater reliability achieved by means of the PANSS. As concerns the positive scale, the intraclass coefficients increased to 0.98-0.99 with the SCID-PANSS. For the negative scale, the intraclass coefficients increased to 0.83-0.90 with the SCID-PANSS, and for the general scale the increase was to 0.95-0.98 with the SCID-PANSS. It was also demonstrated that the interrater reliability is higher for the positive and the negative factors derived from the PANSS than for the positive and the negative scales.

Entities:  

Mesh:

Year:  1994        PMID: 8178678     DOI: 10.1111/j.1600-0447.1994.tb08091.x

Source DB:  PubMed          Journal:  Acta Psychiatr Scand        ISSN: 0001-690X            Impact factor:   6.392


  10 in total

1.  Validity and reliability of the Polish version of the Positive and Negative Syndrome Scale (PANSS).

Authors:  Małgorzata Rzewuska
Journal:  Int J Methods Psychiatr Res       Date:  2002       Impact factor: 4.035

Review 2.  Positive and Negative Syndrome Scale (PANSS) Training: Challenges, Solutions, and Future Directions.

Authors:  Mark G A Opler; Christian Yavorsky; David G Daniel
Journal:  Innov Clin Neurosci       Date:  2017-12-01

3.  Illness-related components for the family burden of relatives to patients with psychotic illness.

Authors:  Fredrik Hjärthag; Lars Helldin; Ulla Karilampi; Torsten Norlander
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2009-05-19       Impact factor: 4.328

4.  Lack of apparent antipsychotic effect of the D1-dopamine receptor antagonist SCH39166 in acutely ill schizophrenic patients.

Authors:  P Karlsson; L Smith; L Farde; C Härnryd; G Sedvall; F A Wiesel
Journal:  Psychopharmacology (Berl)       Date:  1995-10       Impact factor: 4.530

5.  Estimation of Symptom Severity Scores for Patients with Schizophrenia Using ERP Source Activations during a Facial Affect Discrimination Task.

Authors:  Do-Won Kim; Seung-Hwan Lee; Miseon Shim; Chang-Hwan Im
Journal:  Front Neurosci       Date:  2017-08-03       Impact factor: 4.677

6.  EPA guidance on assessment of negative symptoms in schizophrenia.

Authors:  S Galderisi; A Mucci; S Dollfus; M Nordentoft; P Falkai; S Kaiser; G M Giordano; A Vandevelde; M Ø Nielsen; L B Glenthøj; M Sabé; P Pezzella; I Bitter; W Gaebel
Journal:  Eur Psychiatry       Date:  2021-02-18       Impact factor: 5.361

7.  EEG Source Network for the Diagnosis of Schizophrenia and the Identification of Subtypes Based on Symptom Severity-A Machine Learning Approach.

Authors:  Jeong-Youn Kim; Hyun Seo Lee; Seung-Hwan Lee
Journal:  J Clin Med       Date:  2020-12-04       Impact factor: 4.241

8.  Effects of ignoring clustered data structure in confirmatory factor analysis of ordered polytomous items: a simulation study based on PANSS.

Authors:  Jan Stochl; Peter B Jones; Jesus Perez; Golam M Khandaker; Jan R Böhnke; Tim J Croudace
Journal:  Int J Methods Psychiatr Res       Date:  2015-06-20       Impact factor: 4.035

9.  Retinal Layer Abnormalities as Biomarkers of Schizophrenia.

Authors:  Niraj N Samani; Frank A Proudlock; Vasantha Siram; Chathurie Suraweera; Claire Hutchinson; Christopher P Nelson; Mohammed Al-Uzri; Irene Gottlob
Journal:  Schizophr Bull       Date:  2018-06-06       Impact factor: 9.306

10.  Improving Criminal Responsibility Determinations Using Structured Professional Judgment.

Authors:  Marvin W Acklin; Joseph P Velasquez
Journal:  Front Psychol       Date:  2021-07-13
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.